This company has been marked as potentially delisted and may not be actively trading. NASDAQ:AMTI Applied Molecular Transport (AMTI) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Applied Molecular Transport Stock (NASDAQ:AMTI) 30 days 90 days 365 days Advanced Chart Remove Ads Get AMTI alerts:Sign Up Key Stats Today's Range$0.26▼$0.2650-Day Range$0.16▼$0.3152-Week Range$0.13▼$0.84VolumeN/AAverage Volume470,969 shsMarket Capitalization$10.87 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewApplied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of rhIL-10 that is in Phase II clinical trials to treat patients with chronic pouchitis, as well as is in Phase II development to treat patients with rheumatoid arthritis. It develops AMT-126, a GI-selective oral fusion of interleukin 22, which is in a Phase I clinical trial for diseases related to intestinal epithelium barrier function defects. The company, through its technology platform, designs and develops various oral and respiratory biologic therapeutic modalities, such as peptides, proteins, antibodies, antibody fragments, and ribonucleic acid therapeutics. Applied Molecular Transport Inc. was founded in 2010 and is headquartered in South San Francisco, California. As of December 27, 2023, Applied Molecular Transport Inc. operates as a subsidiary of Cyclo Therapeutics, Inc.Read More… Remove Ads Receive AMTI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Applied Molecular Transport and its competitors with MarketBeat's FREE daily newsletter. Email Address AMTI Stock News HeadlinesApplied Molecular Transport Inc (AMTI)July 20, 2024 | investing.comFounders Fund V, LP's Net WorthFebruary 9, 2024 | benzinga.com“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.April 3, 2025 | Weiss Ratings (Ad)Cyclo Therapeutics, Inc. Completes Merger with Applied Molecular Transport Inc.December 27, 2023 | finance.yahoo.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CHS, AMTI, ESMT, CNSLNovember 22, 2023 | benzinga.comApplied Molecular Transport Insider Ups Holding By 239% During YearNovember 22, 2023 | finance.yahoo.comApplied Molecular Transport Inc.: Applied Molecular Transport Reports Third Quarter 2023 Financial ResultsNovember 10, 2023 | finanznachrichten.deApplied Molecular Transport GAAP EPS of -$0.17 beats by $0.33November 9, 2023 | msn.comSee More Headlines AMTI Stock Analysis - Frequently Asked Questions How were Applied Molecular Transport's earnings last quarter? Applied Molecular Transport Inc. (NASDAQ:AMTI) announced its earnings results on Wednesday, November, 10th. The company reported ($0.68) EPS for the quarter, missing the consensus estimate of ($0.62) by $0.06. When did Applied Molecular Transport IPO? Applied Molecular Transport (AMTI) raised $130 million in an IPO on Friday, June 5th 2020. The company issued 10,000,000 shares at a price of $12.00-$14.00 per share. BofA Securities, Jefferies and SVB Leerink acted as the underwriters for the IPO. What other stocks do shareholders of Applied Molecular Transport own? Based on aggregate information from My MarketBeat watchlists, some other companies that Applied Molecular Transport investors own include Meta Platforms (META), BioLife Solutions (BLFS), Micron Technology (MU), Advanced Micro Devices (AMD), Athenex (ATNX), Bristol-Myers Squibb (BMY) and Alibaba Group (BABA). Company Calendar Last Earnings11/10/2021Today4/03/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolNASDAQ:AMTI CIK1801777 Webwww.appliedmt.com Phone650-392-0420FaxN/AEmployees13Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.90) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-126,320,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-223.46% Return on Assets-126.91% Debt Debt-to-Equity RatioN/A Current Ratio4.99 Quick Ratio4.99 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$1.56 per share Price / Book0.17Miscellaneous Outstanding Shares41,337,000Free Float34,764,000Market Cap$10.87 million OptionableOptionable Beta2.28 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free Report This page (NASDAQ:AMTI) was last updated on 4/3/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredNew “Trump” currency proposed in DCAfter a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out firs...Paradigm Press | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Applied Molecular Transport Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Applied Molecular Transport With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.